Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Lionel Hutz on Liquidia's patent battle $LQDA

Lionel Hutz on Liquidia's patent battle $LQDA

FromYet Another Value Podcast


Lionel Hutz on Liquidia's patent battle $LQDA

FromYet Another Value Podcast

ratings:
Length:
80 minutes
Released:
Dec 19, 2022
Format:
Podcast episode

Description

Lionel Hutz discusses his thesis for Liquidia (LQDA) and why the thinks they are likely to win their patent battle against United Therapeutics (UTHR).
Lionel's LQDA write up: https://lionelhutz.substack.com/p/waiting-with-bated-breath-for-liquidia
Chapters 

0:00 Intro 
2:50 LQDA overview 
8:05 Diving into the patent background 
16:10 Breaking down the conflicting rulings on the '793 patent 
19:55 Why the PTAB ruling is the most important for '793 
21:55 What's so unique about the judge's ruling on '793 
28:30 Why PTAB ruled the '793 patent invalid 
37:40 LQDA's primary argument for invalidating '793 
43:30 Discussing the expert reports around the '793 patent 
53:30 Timeline to monetization and why delaying LQDA is so important for UTHR 
59:00 LQDA's upside if they win 
1:13:00 LQDA's cash runway
Released:
Dec 19, 2022
Format:
Podcast episode

Titles in the series (100)

Yet Another Value Podcast is a new podcast from Andrew Walker, the founder of yetanothervalueblog.substack.com/. We interview top investors and dive deep into stocks and companies they are currently working on and investing in. While nothing on this channel is investing advice and everyone should do their own diligence, our goal is to frequently feature edgy and actionable value and/or event driven ideas. Please see our legal and disclaimer at: https://yetanothervalueblog.substack.com/p/legal-and-disclaimer